This topic contains a solution. Click here to go to the answer

Author Question: A neonate is suffering from apnea. Which of the following medications may be administered as a ... (Read 34 times)

tnt_battle

  • Hero Member
  • *****
  • Posts: 556
A neonate is suffering from apnea. Which of the following medications may be administered as a respiratory stimulant?
 
  A) Caffeine and methylphenidate
  B) Caffeine and Mefoxitin
  C) Caffeine and sodium benzoate
  D) Caffeine and sodium bicarbonate

Question 2

A patient is prescribed a proton pump inhibitor to treat erosive gastritis. How soon will the patient's symptoms most likely be abolished?
 
  A) 1 to 2 weeks
  B) 4 weeks
  C) 1 month
  D) 6 weeks



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bookworm410

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

C
Feedback:
The combination of caffeine and sodium benzoate is occasionally used as a respiratory stimulant in neonates. Caffeine is not mixed with methylphenidate. Caffeine is not mixed with Mefoxitin. Caffeine is not mixed with sodium bicarbonate for this indication.

Answer to Question 2

A
Feedback:
The symptoms of gastroesophageal reflux disease will be abolished in 1 to 2 weeks after the start of the proton pump inhibitor medication regime. It will not take 4 weeks, 1 month, or 6 weeks to see a change with the proton pump inhibitor.




tnt_battle

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Excellent


blakcmamba

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library